Jennifer Giordano-Coltart, Ph.D., focuses her practice on patent prosecution, portfolio management, transactional matters, and intellectual property strategy in the life sciences, biotechnology, and medical device fields. She prosecutes patents for clients in the U.S. and abroad and provides patentability, patent validity, infringement, and freedom-to-operate counseling to facilitate her clients’ business goals. In addition, Dr. Giordano-Coltart assists her clients with licensing and acquisitions, including patent analyses and negotiations. She also provides technical assistance on litigation matters and actions before the U.S. Patent and Trademark Office. Dr. Giordano-Coltart’s experience with a wide range of clients—investment groups, start-ups, mid-size and growing companies, and large, established industry leaders—informs her ability to tailor intellectual property strategies to the needs of her clients.

Dr. Giordano-Coltart has broad research experience and knowledge in the life sciences, including molecular biology, biochemistry, genetics, cell biology, immunology, vaccines, physiology, and cancer biology, in addition to biologics, pharmaceuticals, diagnostics, and various medical devices. She conducted her doctoral research at Cornell University Weill Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center, where her research focused on human DNA replication. She has also conducted research in the areas of intracellular trafficking, apoptosis, and human genetic diseases. During law school, Dr. Giordano-Coltart wrote and edited for the Duke Law & Technology Review, in addition to acting as President of the Intellectual Property & Cyberlaw Society. She is a member of the Editorial Board for Current Stem Cell Reports and also regularly publishes on patent law issues of interest to the life science and biotechnology industries, including contributing to Kilpatrick Townsend’s FDA ConneKTion Blog.

Dr. Giordano-Coltart was recognized as a North Carolina "Rising Star" for Intellectual Property Law by Super Lawyers magazine in 2014, 2015, 2016 and 2017.

Professional & Community Activities

American Red Cross, Northwest North Carolina Chapter, Board of Directors, Past Member

Current Stem Cell Reports, Editorial Board, Member

North Carolina Bar Association, Intellectual Property Law Section, Council Member and Biotech & Chemical Patents Committee, Co-Chair

United Way for Forsyth County, Women’s Leadership Counsel Steering Committee, Member

Women in Bio, Research Triangle Park Chapter, Member

Women's Fund of Winston-Salem, Member


  • Duke University School of Law, J.D. (2008)
  • Cornell University, Ph.D., Molecular Biology (2005)
  • University of Alberta, B.S., Biological Sciences - Molecular Genetics (1999)
    with honors

Bar Admissions

  • North Carolina (2008)


  • U.S. District Court for the Middle District of North Carolina (2008)
  • U.S. Patent and Trademark Office (2009)

Who We Are

What fully engaged means to me:

Being fully engaged means being determined, excited about, and invested in helping clients navigate all the issues associated with achieving their goals.

Suite 1400, 4208 Six Forks Road
Raleigh, NC, 27609
t +1 919.420.1716
1001 West Fourth Street
Winston-Salem, NC, 27101-2400
t +1 336.607.7376
f +1 336.232.9771

Jennifer Giordano-Coltart Ph.D.

Experience Highlights

Intellectual property related matters for a clinical laboratory services provider
Represent a clinical laboratory services provider in matters related to intellectual property issues arising in connection with due diligence more
Patent prosecution for research institutions and universities
Represent a number of universities in North Carolina and Georgia in connection with patent prosecution of inventions. more
Patent prosecution for research institute
Represented a medical college in connection with patent prosecution of inventions arising out of research developed at a research institute in more
Datasci, LLC v. Quintiles Transnational Corp.
The firm served as lead counsel on behalf of Quintiles Transnational Corp. in a patent infringement suit relating to electronic data capture more